| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 1535 |
| 1 | PREDNISONE | 742 |
| 2 | FUROSEMIDE | 697 |
| 3 | PREDNISOLONE | 685 |
| 4 | PREDNISOLONE ORAL | 685 |
| 5 | CYCLOPHOSPHAMIDE | 668 |
| 6 | RITUXIMAB | 632 |
| 7 | ASPIRIN | 558 |
| 8 | ASPIRIN 325 MG | 543 |
| 9 | ASPIRIN 81 MG | 543 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLAVOXATE HYDROCHLORIDE | 5 | 0.0575 |
| 1 | METHYLENE BLUE | 51 | 0.0532 |
| 2 | POLATUZUMAB VEDOTIN | 167 | 0.0435 |
| 3 | RHO (D) IMMUNE GLOBULIN | 12 | 0.0387 |
| 4 | ECULIZUMAB | 1535 | 0.0335 |
| 5 | RAVULIZUMAB | 66 | 0.0309 |
| 6 | PRALATREXATE | 17 | 0.0304 |
| 7 | TAFASITAMAB-CXIX | 12 | 0.0300 |
| 8 | ONASEMNOGENE ABEPARVOVEC-XIOI | 44 | 0.0292 |
| 9 | TOREMIFENE CITRATE | 10 | 0.0254 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2091 |
| 1 | Complement Inhibitor [EPC] | 1587 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1112 |
| 3 | Kinase Inhibitor [EPC] | 1001 |
| 4 | Alkylating Drug [EPC] | 865 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 797 |
| 6 | Loop Diuretic [EPC] | 763 |
| 7 | Benzodiazepine [EPC] | 753 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 670 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 645 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Inhibitor [EPC] | 1587 | 0.0333 |
| 1 | CD33-directed Immunoconjugate [EPC] | 65 | 0.0208 |
| 2 | l-Triiodothyronine [EPC] | 1 | 0.0204 |
| 3 | CD123 Interaction [EPC] | 4 | 0.0137 |
| 4 | Tricyclic Antidepressant [EPC] | 5 | 0.0122 |
| 5 | Human Blood Coagulation Factor [EPC] | 3 | 0.0120 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 8 | 0.0118 |
| 7 | Lymphocyte Growth Factor [EPC] | 9 | 0.0100 |
| 8 | Ester Local Anesthetic [EPC] | 4 | 0.0089 |
| 9 | CD22-directed Immunoconjugate [EPC] | 16 | 0.0083 |